Filing Details
- Accession Number:
- 0001225208-10-024869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-12 18:14:44
- Reporting Period:
- 2010-11-10
- Filing Date:
- 2010-11-12
- Accepted Time:
- 2010-11-12 18:14:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1292500 | T John Cardis | One Edwards Way Irvine CA 92614 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-11-10 | 4,590 | $17.43 | 61,518 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-11-10 | 4,590 | $65.66 | 56,928 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director Stock Option (Right to Acquire) | Disposition | 2010-11-10 | 4,590 | $0.00 | 4,590 | $17.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2004-07-01 | 2011-06-30 | No | 4 | M | Direct |
Footnotes
- This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $65.60 to $65.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.